Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset - HMS LINCS Database

Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)

Filter results: >>>>

Cell	Small Molecule	Small Mol Concentration (uM)	Primary Target	Pathway	Mean Normalized Growth Rate Inhibition Value	Increased Fraction Dead
BT-20	Bleomycin	0.01	Radiation	Misc	0.9348	0.00743
BT-20	Bleomycin	0.031667	Radiation	Misc	0.9548	0.00025
BT-20	Bleomycin	0.1	Radiation	Misc	0.8145	0.02731
BT-20	Bleomycin	0.31623	Radiation	Misc	0.6279	0.06555
BT-20	Bleomycin	1.0	Radiation	Misc	0.3200	0.15033
BT-20	Bleomycin	3.1623	Radiation	Misc	-0.0603	0.30083
BT-20	Bleomycin	10.0	Radiation	Misc	-0.1286	0.31597
BT-20	Ipatasertib	0.001	AKT	PI3K/mTOR	0.9147	0.01166
BT-20	Ipatasertib	0.0031623	AKT	PI3K/mTOR	0.9745	-0.00235
BT-20	Ipatasertib	0.01	AKT	PI3K/mTOR	0.9717	-0.00176
BT-20	Ipatasertib	0.031623	AKT	PI3K/mTOR	0.9656	0.00133
BT-20	Ipatasertib	0.1	AKT	PI3K/mTOR	0.7880	0.01344
BT-20	Ipatasertib	0.31623	AKT	PI3K/mTOR	0.5886	0.02673
BT-20	Ipatasertib	1.0	AKT	PI3K/mTOR	0.4168	0.05632
BT-20	Ipatasertib	3.1623	AKT	PI3K/mTOR	0.2981	0.08956
BT-20	Ipatasertib	10.0	AKT	PI3K/mTOR	0.1015	0.23359
BT-20	Alpelisib	0.001	PI3Ka	PI3K/mTOR	1.0513	0.00412
BT-20	Alpelisib	0.0031623	PI3Ka	PI3K/mTOR	1.0511	0.01061
BT-20	Alpelisib	0.01	PI3Ka	PI3K/mTOR	1.0423	0.00240
BT-20	Alpelisib	0.031623	PI3Ka	PI3K/mTOR	0.9920	0.01246
BT-20	Alpelisib	0.1	PI3Ka	PI3K/mTOR	0.9578	0.00889
BT-20	Alpelisib	0.31623	PI3Ka	PI3K/mTOR	0.8237	0.02481
BT-20	Alpelisib	1.0	PI3Ka	PI3K/mTOR	0.6704	0.03335
BT-20	Alpelisib	3.1623	PI3Ka	PI3K/mTOR	0.3868	0.10646
BT-20	Alpelisib	10.0	PI3Ka	PI3K/mTOR	-0.1181	0.37242